Abstract
Transcatheter aortic valve implantation (TAVI) has been shown to effectively expand the therapeutic possibilities in patients with aortic valve disease unfit for aortic valve replacement. However especially the costs and the risk of paravalvular leakage have been recognized as important limitations of these approach. Sutureless aortic valve bioprostheses have been developed to facilitate aortic valve replacement and reduce the duration of aortic cross-clamping and its related adverse events. We have recently compared the results with sutureless Perceval aortic valve bioprostheses versus the transcatheter aortic valve implantation. In this chapter we review the published results of a single center of the TAVI and surgical aortic valve replacement with this sutureless valve bioprostheses.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
